Galectin Therapeutics Inc (FRA:PHPN) Stock News, Headlines & Updates
Galectin Therapeutics Inc Stock News from GuruFocus
- 1
Jul 09, 2025
Galectin Therapeutics (GALT) Secures $10M Credit Line from Key Stockholder | GALT Stock News
GuruFocus News • 7:46am
Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026
Marketwired • 7:00am
Jun 17, 2025
HC Wainwright & Co. Initiates Coverage with Buy Rating on GALT | GALT Stock News
GuruFocus News • 7:00am
Galectin Therapeutics (GALT) Receives Buy Rating from H.C. Wainwright | GALT Stock News
GuruFocus News • 5:16am
Jun 10, 2025
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension | GALT Stock News
GuruFocus News • 8:15am
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
Marketwired • 8:00am
May 15, 2025
Galectin Therapeutics (GALT) Advances in Belapectin Analysis | GALT Stock News
GuruFocus News • 7:31am
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update
Marketwired • 7:00am
May 12, 2025
Galectin Therapeutics (GALT) Reveals Promising NAVIGATE Study Results | GALT Stock News
GuruFocus News • 7:54am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news